Forward this page

Thank you for your interest in spreading the word on FierceVaccines.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bionor's new HIV vaccine moves into clinical trials
(Your Name) has sent you a message from FierceVaccines
(Your Name) thought you would like to see the FierceVaccines web site.

Press Releases

  • To Help Counter Record-High Levels of Cargo Theft, Chubb Adds Covert Shipment Tracking to Suite of Security Services
  • ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
  • The Myelin Repair Foundation Achieves Phase 1 Myelin Repair Clinical Trial
  • Biomet Announces Initial Closing of DePuy Trauma Acquisition
  • KCI Announces FDA 510(k) Clearance of V.A.C. Therapy for Management of Closed Surgical Incisions
  • More Press Releases

Featured Jobs

  • Senior Engineer, Project Job
    Celgene Corporation - Phoenix, AZ, US
  • Director, Regulatory Affairs
    Tesaro - Waltham, MA
  • Forecasting/Analytics Manager
    Sucampo Pharmaceuticals - Washington, DC
  • Scientist Job
    Yoh - Emeryville, CA, USA
  • Senior Manager, API Development
    TESARO - Waltham, MA

Sponsored Links